At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 40 enrolled
Drug / intervention
Vitamin D3 (Cholecalciferol)drug
Likely dose
Vitamin D3 (Cholecalciferol) 3,00,000 Unitsfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Double-blind Randomized Study to Determine the Efficacy of Intramuscular Vitamin D3 Supplementation in Tropical Calcific Pancreatitis
Sanjay Gandhi Postgraduate Institute of Medical Sciences·interventional·Posted Aug 11, 2009·Updated Mar 14, 2013
In Brief
A Phase 4 clinical trial evaluating Vitamin D3 (Cholecalciferol) for Pancreatitis, Chronic. Completed, enrolled 40 participants across 1 site.
Detailed Summary
The purpose of this study is to determine the efficacy of 2 different doses of intramuscular (IM) vitamin D3 as compared to an oral replacement dose in normalizing vitamin D levels in the blood of patients with tropical calcific pancreatitis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPancreatitis, Chronic
CountriesIndia
Collaborators--
Timeline
Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2009
First PostedAug 2009
Primary CompletionJun 2010
Study CompletionDec 2010
TodayJul 2026
First PostedAug 11, 2009
Enrollment StartJul 1, 2009
Primary CompletionJun 1, 2010
Study CompletionDec 1, 2010
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 16.9 years ago
Interventions
Vitamin D3 (Cholecalciferol)drug
Arm 1 - Intramuscular vitamin D3 3,00,000 Units single dose Arm 2 - Intramuscular vitamin D3 6,00,000 Units single dose Arm 3 - Oral vitamin D3 500 Units/day for 6 months